0001628280-25-054549
SEC filingMD&A section contains forward-looking statements on growth strategy and market trends without specific financial metrics or results.
No specific revenue, margin, or earnings figures are provided in the MD&A content.
No segment-level data or mix shifts disclosed.
Management highlights expectations around new products, customer retention, market expansion, and third-party supplier performance as of the filing date. Forward-looking statements reference potential impacts from pandemics, regulatory changes, and competition but provide no quantified outlook or guidance.
Cash and cash equivalents surged to $567.6M from $236.3M at May 3, 2025, driven by $384.6M net proceeds from an ATM offering. Short-term investments of $246.0M (all certificates of deposit) bring total liquidity to $813.6M. The company has no debt. Shareholders' equity rose to $1,286.1M from $681.6M, reflecting net income and the ATM issuance. Inventory increased to $150.2M (up 67% from $90.0M) to support backlog and new product ramps.
Total non-cancelable purchase commitments were $95.3M as of November 1, 2025, comprising $77.4M to manufacturing vendors and $17.8M for technology license fees. Of this, $68.4M is due within 12 months. Additionally, the company has a capacity reservation agreement with an assembly subcontractor requiring minimum purchase levels of $16.2M through fiscal 2028, with $7.3M in refundable deposits. Operating lease obligations total $18.8M, with $2.2M due in the remainder of fiscal 2026.
The company initiated a $750M ATM program in October 2025, raising $384.6M in Q3. No share buybacks or dividends were declared. Capital expenditures were $26.0M (5.3% of sales), primarily for mask sets and R&D equipment. Debt repayments of $4.8M related to technology license obligations. The Hyperlume acquisition cost $92.0M in cash, including $3.3M for vested equity settlement.
The company operates as a single reportable segment. Revenue by geography for the six months ended November 1, 2025: Hong Kong $188.3M (38%), United States $186.5M (38%), Mainland China $75.4M (15%), Rest of World $40.9M (8%). Customer concentration remains high: Customer A accounted for 58% of revenue and 62% of accounts receivable.
For the six months ended November 1, 2025, Credo Technology Group Holding Ltd reported a dramatic improvement in cash generation. Net cash provided by operating activities was $115.8 million, a stark contrast to the $3.0 million provided in the prior-year period. This surge was primarily driven by a swing to net income of $146.0 million from a net loss of $13.8 million, coupled with significant non-cash adjustments, notably $80.8 million in share-based compensation. However, cash flow quality was negatively impacted by substantial working capital investments. Accounts receivable consumed $83.1 million and inventories consumed $66.4 million, reflecting the company's rapid growth and scaling of operations.
Investing activities used $159.6 million in net cash. While capital expenditures of $26.0 million remained consistent with the prior year's $27.8 million, the period included an $82.6 million outflow for a business acquisition, net of cash acquired. The company also made net purchases of short-term investments totaling $51.0 million. Financing activities provided a significant $374.9 million inflow, almost entirely attributable to $384.6 million in net proceeds from an At-The-Market (ATM) equity offering. This capital raise substantially bolstered the company's cash position, ending the period with $567.6 million in cash and equivalents. No share repurchases or dividends were paid. The company's free cash flow (operating cash flow less capex) was approximately $89.8 million, indicating strong organic cash generation before acquisition-related spending.